Larvol Delta - CERo-Therapeutics-Holdings-Inc-Announces-Critical-Patent-Application-Allowances-from-the-US-Patent-Ofce-Covering-Companys-Lead-Compound-CER1236

CER-1236 - CERo Therap

https://www.globenewswire.com/news-release/2025/04/10/3059221/0/en/CERo-Therapeutics-Holdings-Inc-Announces-Critical-Patent-Application-Allowances-from-the-U-S-Patent-Office-Covering-Company-s-Lead-Compound-CER-1236.html

Apr 10, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next